Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB01042_nanopub.RA9osfaOT_cJuL5kviHeEjl2umgFABIfS09a59F2TRn-E#assertion>. }
Showing items 1 to 24 of
24
with 100 items per page.
- drugbank:DB01042 type drugbank_vocabulary:Drug assertion.
- drugbank:DB01042 label "Melphalan [drugbank:DB01042]" assertion.
- drugbank:DB01042 seeAlso DB01042 assertion.
- drugbank:DB01042 seeAlso melphalan.html assertion.
- drugbank:DB01042 seeAlso melph.htm assertion.
- drugbank:DB01042 identifier "drugbank:DB01042" assertion.
- drugbank:DB01042 description "An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - melphalan, the racemic mixture - merphalan, and the dextro isomer - medphalan; toxic to bone marrow, but little vesicant action; potential carcinogen. [PubChem]" assertion.
- drugbank:DB01042 title "Melphalan" assertion.
- drugbank:DB01042 bio2rdf_vocabulary:identifier "DB01042" assertion.
- drugbank:DB01042 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB01042 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB01042" assertion.
- drugbank:DB01042 bio2rdf_vocabulary:x-identifiers.org DB01042 assertion.
- drugbank:DB01042 drugbank_vocabulary:drugbank-id "APRD00118" assertion.
- drugbank:DB01042 drugbank_vocabulary:drugbank-id "DB01042" assertion.
- drugbank:DB01042 drugbank_vocabulary:x-cas cas:148-82-3 assertion.
- drugbank:DB01042 drugbank_vocabulary:x-ahfs ahfs:10:00.00 assertion.
- drugbank:DB01042 drugbank_vocabulary:x-atc atc:L01AA03 assertion.
- drugbank:DB01042 drugbank_vocabulary:x-chebi chebi:28876 assertion.
- drugbank:DB01042 drugbank_vocabulary:x-dpd dpd:4715 assertion.
- drugbank:DB01042 drugbank_vocabulary:x-kegg kegg:D00369 assertion.
- drugbank:DB01042 drugbank_vocabulary:x-pharmgkb pharmgkb:PA450354 assertion.
- drugbank:DB01042 drugbank_vocabulary:x-wikipedia wikipedia:Melphalan assertion.
- drugbank:DB01042 drugbank_vocabulary:x-bindingdb bindingdb:50038356 assertion.
- drugbank:DB01042 drugbank_vocabulary:x-ndc ndc:0173-0045-35 assertion.